跳转至内容
Merck
CN

D045

Sigma-Aldrich

1-甲基-4-苯基-1,2,3,6-四氢吡啶 盐酸盐

别名:

MPTP 盐酸盐

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C12H15N · HCl
化学文摘社编号:
分子量:
209.72
Beilstein:
3707312
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

SMILES字符串

Cl[H].CN1CCC(=CC1)c2ccccc2

InChI

1S/C12H15N.ClH/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11;/h2-7H,8-10H2,1H3;1H

InChI key

KOWJANGMTAZWDT-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

生化/生理作用

多巴胺能神经毒素。

免责声明

据报道可在人和猴中导致严重且不可逆转的帕金森症状。

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

J D Elsworth et al.
Experimental neurology, 211(1), 252-258 (2008-03-19)
Neural transplantation offers the potential of treating Parkinson's disease by grafting fetal dopamine neurons to depleted regions of the brain. However, clinical studies of neural grafting in Parkinson's disease have produced only modest improvements. One of the main reasons for
Fei Sa et al.
Neuroscience letters, 593, 7-12 (2015-03-17)
Dibenzocyclooctadiene lignans represent a unique group of natural chemical structures, are considered as protectants against neuronal cell death and cognitive impairment in neurological disorders. Among the family of dibenzocyclooctadiene lignan analogs from the fruit of Schisandra chinensis (Turcz.) Baill, neuroprotective
Milena Cannella et al.
Neuropharmacology, 95, 50-58 (2015-03-10)
Neuroadaptive changes involving the indirect pathway of the basal ganglia motor circuit occur in the early phases of parkinsonism. The precise identification of these changes may shed new light into the pathophysiology of parkinsonism and better define the time window
WeiZhen Liu et al.
European journal of pharmacology, 765, 284-290 (2015-08-25)
Oxyntomodulin is a hormone and a growth factor. It activates two receptors, the Glucagon-like peptide 1 (GLP-1) and the glucagon receptor. GLP-1 mimetics are on the market as treatments for type 2 diabetes and are well tolerated. These drugs have
Philippe Huot et al.
Neuropharmacology, 82, 76-87 (2014-01-23)
L-3,4-Dihydroxyphenylalanine (L-DOPA) is the most effective treatment for Parkinson's disease (PD), but its long-term administration is complicated by wearing-off and dyskinesia. UWA-101, a dual, equipotent inhibitor of dopamine (DAT) and serotonin (SERT) transporters, has previously been shown to successfully extend

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持